• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, July 29, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

HIB vaccine linked with better health, cognition, and schooling outcomes in Indian children

Bioengineer by Bioengineer
June 12, 2019
in Health
Reading Time: 2 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Researchers at CDDEP, the University of California, Riverside and Harvard T.H. Chan School of Public Health assessed the long-term associations of the Hib vaccine with anthropometric, cognitive, and schooling outcomes among Indian children

Washington, DC – India accounts for the highest number of Haemophilus influenzae type b (Hib) cases and Hib- associated deaths in the world. The bacterial pathogen killed an estimated 15,600 Indian children aged 1-59 months in 2015. In a majority of cases, Hib causes pneumonia and bacterial meningitis, which can lead to long-term consequences in children under age five such as stunting, decreased productivity and schooling outcomes, and increased risk of other diseases. Hib immunization was incorporated into the pentavalent vaccine in India in 2011 and now protects 88 percent of Indian children under age two, although the Hib burden remains high. While the long-term negative effects of Hib infection in high-income countries are known, little evidence exists on the associated outcomes of Hib infection in low- and middle- income countries.

To investigate the associations between Hib vaccination status and anthropometric, cognitive, and schooling outcomes among Indian children, researchers examined Z-scores of height- for-age (HAZ) and BMI-for-age (BMIZ), percentage scores of English, mathematics, reading, and Peabody Picture Vocabulary tests, and highest schooling grade attainment among 1,824 Hib-vaccinated and unvaccinated children. Propensity score matching was used to control for systematic differences between the two groups.

Researchers analyzed data on reported vaccination receipts, household socioeconomic characteristics, and child anthropometric, cognitive, and schooling outcomes in India from a cohort of children enrolled in the Young Lives Survey (YLS), a longitudinal study assessing childhood poverty. Anthropometric, cognition, and schooling indicators were evaluated across Hib-vaccination groups using the 2013 and 2016 YLS surveys.

The study found that at ages 11-12 years, Hib-vaccinated children had significantly higher HAZ scores (an increase of 0.25, P

Overall, results indicate that Hib vaccination prior to age six is associated with improved long-term health, cognition, and schooling outcomes among children in India, which also implies an associated economic gain.

“Hib vaccination is a critical component of the pentavalent vaccine, which was introduced in 2011. Although we tend to focus on short term consequences of immunization, this study shows that the effect of Hib vaccination on schooling and cognitive development can be significant. Denying children vaccines is effectively denying them access to these benefits that persist through their lives” according to study co-author and CDDEP director, Ramanan Laxminarayan.

###

The study titled, “Haemophilus influenzae type b vaccination and anthropometric, cognitive, and schooling outcomes among Indian children” was published on June 10, 2019 in Annals of the New York Academy of Sciences and is available online here.

About the Center for Disease Dynamics, Economics & Policy

The Center for Disease Dynamics, Economics & Policy (CDDEP) produces independent, multidisciplinary research to advance the health and wellbeing of human populations around the world. CDDEP projects are global in scope, spanning Africa, Asia, and North America and include scientific studies and policy engagement. The CDDEP team is experienced in addressing country-specific and regional issues, as well as the local and global aspects of global challenges, such as antibiotic resistance and pandemic influenza. CDDEP research is notable for innovative approaches to design and analysis, which are shared widely through publications, presentations and web-based programs. CDDEP has offices in Washington, D.C. and New Delhi and relies on a distinguished team of scientists, public health experts and economists.

Media Contact
Kayli Hiban
[email protected]

Tags: EducationMedicine/HealthVaccines
Share12Tweet7Share2ShareShareShare1

Related Posts

blank

Novel Plasma Synuclein Test Advances Parkinson’s Diagnosis

July 29, 2025
blank

Obesity’s Impact on Pancreatic Surgery Outcomes Compared

July 28, 2025

Virion Movement in Sialoglycan-Cleaving Respiratory Viruses

July 28, 2025

Bariatric Surgery’s Impact on Circulating S100A9

July 28, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    54 shares
    Share 22 Tweet 14
  • USF Research Unveils AI Technology for Detecting Early PTSD Indicators in Youth Through Facial Analysis

    42 shares
    Share 17 Tweet 11
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    45 shares
    Share 18 Tweet 11
  • Engineered Cellular Communication Enhances CAR-T Therapy Effectiveness Against Glioblastoma

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Novel Plasma Synuclein Test Advances Parkinson’s Diagnosis

Advancing Microbial Risk Assessment Through Detection Technology Evolution

Obesity’s Impact on Pancreatic Surgery Outcomes Compared

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.